Comorbidity and low use of new antiplatelets in acute coronary syndrome.

MLA

Aboal, Jaime, et al. “Comorbidity and Low Use of New Antiplatelets in Acute Coronary Syndrome.” Aging Clinical and Experimental Research, vol. 32, no. 8, Aug. 2020, pp. 1525–31. EBSCOhost, https://doi.org/10.1007/s40520-019-01348-7.

APA

Aboal, J., Llaó, I., García García, C., Sans-Roselló, J., Sambola, A., Andrea, R., Tomás, C., Bonet, G., Ariza-Solé, A., Viñas, D., Oliveras Vilà, T., Montero, S., Cantalapiedra, J., Pujol-López, M., Hernández, I., Pérez-Rodriguez, M., Loma-Osorio, P., & Sánchez-Salado, J. C. (2020). Comorbidity and low use of new antiplatelets in acute coronary syndrome. Aging Clinical and Experimental Research, 32(8), 1525–1531. https://doi.org/10.1007/s40520-019-01348-7

Chicago

Aboal, Jaime, Isaac Llaó, Cosme García García, Jordi Sans-Roselló, Antonia Sambola, Rut Andrea, Carlos Tomás, et al. 2020. “Comorbidity and Low Use of New Antiplatelets in Acute Coronary Syndrome.” Aging Clinical and Experimental Research 32 (8): 1525–31. doi:10.1007/s40520-019-01348-7.